Economic Evaluation of Changes in Reimbursement for Medications Purchased Through the 340B Drug Pricing Program.

The Centers for Medicare and Medicaid Services (CMS) implemented changes to the reimbursement scheme for 340B-acquired medications on January 1, 2018, reducing payments by approximately 25%. It was recognized that these changes would have a significant fiscal impact to Medical University of South Carolina (MUSC) Health. The purpose of this assessment was to review the financial impact of changes in Medicare reimbursement for clinic-administered medications.

Drug-Induced Ototoxicity: A Comprehensive Review and Reference Guide.

Objective: In an era of increasing polypharmacy, adverse drug effects such as ototoxicity have significant public health implications. Despite the availability of evidence, many health care professionals may not know the risk of ototoxicity in common medications. Therefore, the aim of this review is to provide a comprehensive, easy to use, ototoxic profile of medications with an assessment of supporting evidence.

Encouraging pharmacist intervention and standardization of labeling and dispensing of oral liquid medications.

Objectives: To initiate a call to action for community pharmacists and key-pharmacy stakeholders in the standardization of oral-liquid dosage forms.

Data Sources: Not applicable.

Summary: Unintentional overdose of medication due to administration error results in thousands of pediatric hospitalizations yearly.